HIV in Canada—Supplementary tables, 2016
Volume 43-12, December 7, 2017: Can we eliminate HIV?
Web exclusive
HIV in Canada—Supplementary tables, 2016
AC Bourgeois1, M Edmunds1, A Awan1,2, L Jonah1, O Varsaneux1, W Siu1
Affiliations
1 Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON
2 Dalla Lana School of Public Health, University of Toronto, Toronto, ON
Correspondence
Suggested citation
AC Bourgeois, M Edmunds, A Awan, L Jonah, O Varsaneux, W Siu. HIV in Canada – Supplementary tables, 2016. Can Commun Dis Rep. 2017;43(12). Web exclusive. https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-12-december-7-2017/hiv-2016-supplementary-tables.html
This article provides supplementary data for the surveillance report in this issue entitled: HIV in Canada—Surveillance Report, 2016Footnote 1
Submit a manuscript
About CCDR
Browse
Province/Territory | Year of test | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | |
British Columbia | ||||||||||
Male | 14.2 | 13.2 | 12.1 | 10.7 | 10.9 | 9.2 | 10.2 | 9.3 | 8.6 | 9.0 |
Female | 3.9 | 2.7 | 3.2 | 2.7 | 1.9 | 1.3 | 1.3 | 1.9 | 1.6 | 1.7 |
Total | 9.1 | 7.9 | 7.6 | 6.7 | 6.4 | 5.2 | 5.7 | 5.6 | 5.1 | 5.3 |
Yukon | ||||||||||
Male | 0.0 | 5.9 | 11.5 | 0.0 | 5.5 | 5.4 | 5.4 | 10.6 | 5.3 | 0.0 |
Female | 0.0 | 6.2 | 6.0 | 5.9 | 0.0 | 0.0 | 0.0 | 5.5 | 0.0 | 10.8 |
Total | 0.0 | 6.0 | 8.8 | 2.9 | 2.8 | 2.8 | 2.8 | 8.1 | 2.7 | 5.3 |
Alberta | ||||||||||
Male | 8.8 | 8.2 | 8.0 | 7.8 | 8.0 | 8.7 | 8.8 | 9.2 | 6.9 | 9.1 |
Female | 3.9 | 4.6 | 3.8 | 3.0 | 3.7 | 3.6 | 4.0 | 4.5 | 4.3 | 4.0 |
Total | 6.4 | 6.4 | 5.9 | 5.4 | 5.9 | 6.2 | 6.5 | 6.9 | 5.6 | 6.6 |
Northwest Territories | ||||||||||
Total | DS | DS | DS | DS | DS | DS | DS | DS | DS | DS |
Nunavut | ||||||||||
Total | DS | DS | DS | DS | DS | DS | DS | DS | DS | DS |
Saskatchewan | ||||||||||
Male | 13.0 | 18.7 | 21.2 | 20.6 | 20.3 | 19.8 | 15.6 | 13.9 | 18.0 | 16.5 |
Female | 12.2 | 15.4 | 17.1 | 12.5 | 14.8 | 13.8 | 8.0 | 7.9 | 11.0 | 13.6 |
Total | 12.6 | 17.0 | 19.1 | 16.6 | 17.6 | 16.9 | 11.8 | 10.9 | 14.5 | 15.1 |
Manitoba | ||||||||||
Male | 8.6 | 8.9 | 9.5 | 13.8 | 7.7 | 6.7 | 11.3 | 8.4 | 10.8 | 13.0 |
Female | 4.0 | 5.8 | 7.5 | 6.0 | 4.8 | 4.6 | 7.4 | 5.1 | 5.4 | 6.0 |
Total | 6.3 | 7.3 | 8.5 | 9.9 | 6.2 | 5.7 | 9.3 | 6.8 | 8.1 | 9.5 |
Ontario | ||||||||||
Male | 12.4 | 12.7 | 11.6 | 12.3 | 11.7 | 10.1 | 9.9 | 9.7 | 9.9 | 10.1 |
Female | 3.5 | 4.0 | 3.2 | 2.7 | 3.0 | 2.7 | 1.9 | 2.4 | 2.3 | 2.5 |
Total | 7.9 | 8.4 | 7.4 | 7.5 | 7.4 | 6.4 | 5.9 | 6.0 | 6.1 | 6.3 |
QuebecFootnote ‡ | ||||||||||
Male | 10.6 | 12.7 | 10.2 | 9.1 | 9.3 | 8.7 | 8.4 | 7.9 | 8.7 | 11.5 |
Female | 3.2 | 3.7 | 2.9 | 2.9 | 2.6 | 2.2 | 2.6 | 2.7 | 2.7 | 2.8 |
Total | 6.9 | 8.2 | 6.5 | 6.0 | 5.9 | 5.5 | 5.5 | 5.3 | 5.7 | 7.1 |
New Brunswick | ||||||||||
Male | 2.5 | 2.7 | 0.3 | 2.1 | 2.1 | 1.1 | 1.6 | 0.8 | 1.3 | 0.5 |
Female | 1.3 | 1.1 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.3 | 1.0 | 1.3 |
Total | 1.9 | 1.9 | 0.1 | 1.1 | 1.3 | 0.5 | 0.8 | 0.5 | 1.2 | 0.9 |
Nova Scotia | ||||||||||
Male | 4.0 | 4.2 | 2.4 | 2.6 | 2.8 | 3.9 | 2.8 | 2.8 | 3.2 | 2.4 |
Female | 0.4 | 0.4 | 0.4 | 0.6 | 0.4 | 0.0 | 0.6 | 0.0 | 0.4 | 0.6 |
Total | 2.1 | 2.2 | 1.4 | 1.6 | 1.6 | 1.9 | 1.7 | 1.4 | 1.8 | 1.5 |
Prince Edward Island | ||||||||||
Total | DS | DS | DS | DS | DS | DS | DS | DS | DS | DS |
Newfoundland and LabradorFootnote § | ||||||||||
Male | 0.0 | 0.8 | 1.6 | 1.3 | 0.8 | 1.9 | 1.6 | 2.7 | 2.7 | 1.9 |
Female | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.4 | 1.1 | 0.4 | 0.4 |
Total | 0.0 | 0.6 | 1.2 | 1.0 | 0.6 | 1.7 | 1.3 | 2.5 | 2.1 | 1.5 |
Grand Total | 7.3 | 7.8 | 7.0 | 6.7 | 6.6 | 5.9 | 5.8 | 5.8 | 5.8 | 6.4 |
Grand total males | 11.7 | 11.5 | 10.4 | 10.3 | 10.0 | 9.1 | 9.1 | 8.7 | 8.8 | 9.8 |
Grand total females | 3.6 | 4.0 | 3.6 | 3.1 | 3.1 | 2.7 | 2.5 | 2.8 | 2.8 | 3.0 |
Province/territory | Year of test | Total | ||||||
---|---|---|---|---|---|---|---|---|
1985-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote ¥ | |
British Columbia | ||||||||
Male | 11,841 | 208 | 234 | 215 | 202 | 213 | 12,913 | 19.4 |
Female | 2,089 | 29 | 31 | 44 | 37 | 40 | 2,270 | 14.9 |
Total | 14,274 | 237 | 265 | 261 | 239 | 253 | 15,529 | 18.4 |
Yukon | ||||||||
Male | 39 | 1 | 1 | 2 | 1 | 0 | 44 | 0.1 |
Female | 16 | 0 | 0 | 1 | 0 | 2 | 19 | 0.1 |
Total | 55 | 1 | 1 | 3 | 1 | 2 | 63 | 0.1 |
Alberta | ||||||||
Male | 4,471 | 173 | 180 | 193 | 148 | 197 | 5,362 | 8.1 |
Female | 1,204 | 69 | 80 | 91 | 89 | 84 | 1,617 | 10.6 |
Total | 5,675 | 242 | 261 | 284 | 237 | 282 | 6,981 | 8.3 |
Northwest Territories | ||||||||
Male | DS | DS | DS | DS | DS | DS | 45 | 0.1 |
Female | DS | DS | DS | DS | DS | DS | 12 | 0.1 |
Total | 51 | DS | DS | DS | DS | DS | 57 | 0.1 |
NunavutFootnote † | ||||||||
Male | DS | DS | DS | DS | DS | DS | 4 | 0.0 |
Female | DS | DS | DS | DS | DS | DS | 0 | 0.0 |
Total | DS | DS | DS | DS | DS | DS | 6 | 0.0 |
Saskatchewan | ||||||||
Male | 936 | 109 | 87 | 79 | 103 | 96 | 1,410 | 2.1 |
Female | 618 | 75 | 44 | 44 | 62 | 78 | 921 | 6.1 |
Total | 1,564 | 184 | 131 | 123 | 165 | 174 | 2,341 | 2.8 |
Manitoba | ||||||||
Male | 1,337 | 42 | 71 | 54 | 70 | 86 | 1,660 | 2.5 |
Female | 506 | 29 | 47 | 33 | 35 | 40 | 690 | 4.5 |
Total | 1,843 | 71 | 118 | 87 | 105 | 126 | 2,350 | 2.8 |
Ontario | ||||||||
Male | 26,236 | 670 | 659 | 655 | 674 | 696 | 29,590 | 44.5 |
Female | 4,867 | 186 | 132 | 167 | 161 | 177 | 5,690 | 37.4 |
Total | 32,113 | 861 | 797 | 828 | 839 | 881 | 36,319 | 43.0 |
QuebecFootnote ‡ | ||||||||
Male | 12,305 | 351 | 342 | 322 | 359 | 476 | 14,155 | 21.3 |
Female | 3,203 | 91 | 107 | 113 | 114 | 117 | 3,745 | 24.6 |
Total | 16,714 | 443 | 453 | 435 | 473 | 593 | 19,111 | 22.6 |
New Brunswick | ||||||||
Male | 354 | 4 | 6 | 3 | 5 | 2 | 374 | 0.6 |
Female | 60 | 0 | 0 | 1 | 4 | 5 | 70 | 0.5 |
Total | 414 | 4 | 6 | 4 | 9 | 7 | 444 | 0.5 |
Nova Scotia | ||||||||
Male | 659 | 18 | 13 | 13 | 15 | 11 | 729 | 1.1 |
Female | 106 | 0 | 3 | 0 | 2 | 3 | 114 | 0.7 |
Total | 765 | 18 | 16 | 13 | 17 | 14 | 843 | 1.0 |
Prince Edward Island | ||||||||
Male | DS | DS | DS | DS | DS | DS | 32 | 0.0 |
Female | DS | DS | DS | DS | DS | DS | 9 | 0.1 |
Total | 44 | DS | DS | DS | DS | DS | 53 | 0.1 |
Newfoundland and LabradorFootnote § | ||||||||
Male | 210 | 7 | 6 | 10 | 10 | 7 | 250 | 0.4 |
Female | 54 | 2 | 1 | 3 | 1 | 1 | 62 | 0.4 |
Total | 264 | 9 | 7 | 13 | 11 | 8 | 312 | 0.4 |
Grand Total | 73,779 | 2,073 | 2,060 | 2,053 | 2,100 | 2,344 | 84,409 | 100 |
Grand total male | 58,456 | 1,584 | 1,603 | 1,548 | 1,589 | 1,788 | 66,568 | 100 |
Grand total female | 12,741 | 483 | 446 | 497 | 505 | 547 | 15,219 | 100 |
Province/territory | Age group (years) | Total | |||||
---|---|---|---|---|---|---|---|
Under 15 | 15-19 | 20-29 | 30-39 | 40-49 | 50 and up | n | |
2016 | |||||||
British Columbia | 0 | 4 | 66 | 71 | 43 | 68 | 252 |
Yukon | 0 | 0 | 0 | 1 | 0 | 1 | 2 |
Alberta | 1 | 7 | 62 | 98 | 65 | 49 | 282 |
Northwest Territories | DS | DS | DS | DS | DS | DS | DS |
Nunavut | DS | DS | DS | DS | DS | DS | DS |
Saskatchewan | 1 | 6 | 42 | 54 | 36 | 35 | 174 |
Manitoba | 1 | 3 | 20 | 33 | 42 | 27 | 126 |
Ontario | 8 | 18 | 217 | 261 | 184 | 191 | 879 |
Quebec† | 2 | 10 | 106 | 148 | 135 | 192 | 593 |
New Brunswick | 0 | 0 | 2 | 2 | 1 | 2 | 7 |
Nova Scotia | 0 | 0 | 7 | 1 | 6 | 0 | 14 |
Prince Edward Island | DS | DS | DS | DS | DS | DS | DS |
Newfoundland and LabradorFootnote ‡ | 0 | 0 | 2 | 2 | 2 | 2 | 8 |
2016 TotalFootnote § Footnote ¥ | 13 | 48 | 526 | 672 | 514 | 568 | 2,341 |
2015 | |||||||
British Columbia | 0 | 5 | 57 | 57 | 51 | 69 | 239 |
Yukon | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
Alberta | 1 | 5 | 57 | 73 | 60 | 41 | 237 |
Northwest Territories | DS | DS | DS | DS | DS | DS | DS |
Nunavut | DS | DS | DS | DS | DS | DS | DS |
Saskatchewan | 4 | 4 | 43 | 45 | 35 | 34 | 165 |
Manitoba | 0 | 1 | 25 | 22 | 34 | 23 | 105 |
Ontario | 4 | 18 | 235 | 239 | 178 | 165 | 839 |
QuebecFootnote † | 3 | 6 | 87 | 128 | 88 | 161 | 473 |
New Brunswick | 0 | 0 | 2 | 1 | 1 | 5 | 9 |
Nova Scotia | 0 | 1 | 10 | 3 | 3 | 0 | 17 |
Prince Edward Island | DS | DS | DS | DS | DS | DS | DS |
Newfoundland and LabradorFootnote ‡ | 0 | 0 | 2 | 3 | 4 | 2 | 11 |
2015 TotalFootnote ¥ | 12 | 40 | 518 | 573 | 454 | 501 | 2,098 |
Age and sex | Number of cases reported | %Footnote † |
---|---|---|
Children (< 15 years old) | ||
Males | 364 | 56.4 |
Females | 281 | 43.6 |
Sex not reported/other | 12 | n/a |
Total | 657 | 0.8 |
Adults (≥15 years old)Footnote ‡ | ||
Males | 64,127 | 81.3 |
Females | 14,758 | 18.7 |
Sex not reported/other | 1,249 | n/a |
Total | 80,134 | 99.2 |
Age group not reported | ||
Males | 2,077 | n/a |
Females | 180 | n/a |
Sex not reported/other | 1,361 | n/a |
Total | 3,618 | n/a |
Total | ||
Males | 66,568 | 81.4 |
Females | 15,219 | 18.6 |
Sex not reported/other | 2,622 | n/a |
Grand Total | 84,409 | 100.0 |
Year of diagnosis | Males | Females | Sex not reported/ transsexual/transgender | Total | ||||
---|---|---|---|---|---|---|---|---|
Number of cases | Cumulative total | Number of cases | Cumulative total | Number of cases | Cumulative total | Number of cases | Cumulative total | |
1985-2005 | 45,382 | 45,382 | 8,752 | 8,752 | 1,172 | 1,172 | 55,306 | 55,306 |
2006 | 1,793 | 47,175 | 683 | 9,435 | 6 | 1,178 | 2,482 | 57,788 |
2007 | 1,776 | 48,951 | 589 | 10,024 | 7 | 1,185 | 2,372 | 60,160 |
2008 | 1,903 | 50,854 | 658 | 10,682 | 4 | 1,189 | 2,565 | 62,725 |
2009 | 1,740 | 52,594 | 593 | 11,275 | 6 | 1,195 | 2,339 | 65,064 |
2010 | 1,747 | 54,341 | 516 | 11,791 | 11 | 1,206 | 2,274 | 67,338 |
2011 | 1,713 | 56,054 | 527 | 12,318 | 11 | 1,217 | 2,251 | 69,589 |
2012 | 1,574 | 57,628 | 476 | 12,794 | 5 | 1,222 | 2,055 | 71,644 |
2013 | 1,591 | 59,219 | 435 | 13,229 | 9 | 1,231 | 2,035 | 73,679 |
2014 | 1,543 | 60,762 | 491 | 13,720 | 7 | 1,238 | 2,041 | 75,720 |
2015 | 1,584 | 62,346 | 498 | 14,218 | 4 | 1,242 | 2,086 | 77,806 |
2016 | 1,781 | 64,127 | 540 | 14,758 | 7 | 1,249 | 2,328 | 80,134 |
TotalFootnote * | 64,127 | n/a | 14,758 | n/a | 1,249 | n/a | 80,134 | n/a |
Age and Sex | Year of test | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote ‡ | |||||||
n | % | n | % | n | % | n | % | n | % | n | % | |||
Children < 15 years | ||||||||||||||
Male | 330 | 0.6 | 9 | 0.6 | 10 | 0.6 | 4 | 0.3 | 5 | 0.3 | 6 | 0.3 | 364 | 0.6 |
Female | 243 | 1.9 | 7 | 1.4 | 11 | 2.5 | 6 | 1.2 | 7 | 1.4 | 7 | 1.3 | 281 | 1.9 |
Total | 585 | 0.8 | 16 | 0.8 | 21 | 1.0 | 10 | 0.5 | 12 | 0.6 | 13 | 0.6 | 657 | 0.8 |
15 to 19 years | ||||||||||||||
Male | 618 | 1.1 | 22 | 1.4 | 26 | 1.6 | 24 | 1.6 | 21 | 1.3 | 28 | 1.6 | 739 | 1.1 |
Female | 496 | 3.9 | 14 | 2.9 | 12 | 2.7 | 13 | 2.6 | 19 | 3.8 | 20 | 3.7 | 574 | 3.8 |
Total | 1,124 | 1.6 | 36 | 1.7 | 38 | 1.8 | 37 | 1.8 | 40 | 1.9 | 48 | 2.1 | 1,323 | 1.6 |
20 to 29 years | ||||||||||||||
Male | 13,283 | 23.6 | 355 | 22.4 | 356 | 22.2 | 350 | 22.6 | 401 | 25.2 | 405 | 22.7 | 15,150 | 23.5 |
Female | 3,990 | 31.5 | 114 | 23.6 | 98 | 22.0 | 86 | 17.3 | 115 | 22.8 | 120 | 21.9 | 4,523 | 29.9 |
Total | 17,544 | 25.0 | 471 | 22.7 | 455 | 22.1 | 438 | 21.4 | 518 | 24.7 | 526 | 22.5 | 19,952 | 24.7 |
30 to 39 years | ||||||||||||||
Male | 21,909 | 38.9 | 438 | 27.7 | 437 | 27.3 | 470 | 30.4 | 416 | 26.2 | 495 | 27.7 | 24,165 | 37.5 |
Female | 4,632 | 36.6 | 166 | 34.4 | 159 | 35.7 | 175 | 35.2 | 157 | 31.1 | 174 | 31.8 | 5,463 | 36.1 |
Total | 26,986 | 38.5 | 606 | 29.3 | 598 | 29.1 | 648 | 31.6 | 573 | 27.3 | 672 | 28.7 | 30,083 | 37.2 |
40 to 49 years | ||||||||||||||
Male | 13,440 | 23.8 | 462 | 29.2 | 409 | 25.5 | 355 | 22.9 | 347 | 21.8 | 396 | 22.2 | 15,409 | 23.9 |
Female | 2,196 | 17.3 | 113 | 23.4 | 100 | 22.4 | 113 | 22.7 | 107 | 21.2 | 115 | 21.0 | 2,744 | 18.1 |
Total | 15,871 | 22.6 | 575 | 27.8 | 512 | 24.9 | 468 | 22.8 | 454 | 21.6 | 514 | 22.0 | 18,394 | 22.8 |
≥50 years | ||||||||||||||
Male | 6,028 | 10.7 | 297 | 18.8 | 363 | 22.7 | 344 | 22.2 | 399 | 25.1 | 457 | 25.6 | 7,888 | 12.2 |
Female | 1,015 | 8.0 | 69 | 14.3 | 66 | 14.8 | 104 | 20.9 | 100 | 19.8 | 111 | 20.3 | 1,465 | 9.7 |
Total | 7,147 | 10.2 | 367 | 17.7 | 432 | 21.0 | 450 | 21.9 | 501 | 23.9 | 568 | 24.3 | 9,465 | 11.7 |
Adult, age unknownFootnote § | ||||||||||||||
Male | 776 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 776 | 1.2 |
Female | 88 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | 0.6 |
Total | 917 | 1.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 917 | 1.1 |
Total all ages | ||||||||||||||
Male | 56,384 | 100 | 1,583 | 100 | 1,601 | 100 | 1,547 | 100 | 1,589 | 100 | 1,787 | 100 | 64,491 | 100 |
Female | 12,659 | 100 | 483 | 100 | 446 | 100 | 497 | 100 | 505 | 100 | 547 | 100 | 15,137 | 100 |
Total | 70,174 | 100 | 2,071 | 100 | 2,056 | 100 | 2,051 | 100 | 2,098 | 100 | 2,341 | 100 | 80,791 | 100 |
Total Adults | ||||||||||||||
Male | 56,054 | n/a | 1,574 | n/a | 1,591 | n/a | 1,543 | n/a | 1,584 | n/a | 1,781 | n/a | 64,127 | n/a |
Female | 12,416 | n/a | 476 | n/a | 435 | n/a | 491 | n/a | 498 | n/a | 540 | n/a | 14,856 | n/a |
Total | 69,589 | n/a | 2,055 | n/a | 2,035 | n/a | 2,041 | n/a | 2,086 | n/a | 2,328 | n/a | 80,134 | n/a |
Age group not reported | ||||||||||||||
Total | 3,605 | n/a | 2 | n/a | 4 | n/a | 2 | n/a | 2 | n/a | 3 | n/a | 3,618 | n/a |
Grand Total | 73,779 | n/a | 2,073 | n/a | 2,060 | n/a | 2,053 | n/a | 2,100 | n/a | 2,344 | n/a | 84,409 | n/a |
Exposure category | Exposure sub-category | Year of test | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote † | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
MSM | n/a | 21,730 | 54.2 | 665 | 46.7 | 674 | 48.4 | 669 | 48.5 | 624 | 44.9 | 633 | 44.1 | 24,995 | 53.1 |
MSM/IDU | n/a | 1,039 | 2.6 | 30 | 2.1 | 38 | 2.7 | 38 | 2.8 | 43 | 3.1 | 55 | 3.8 | 1,243 | 2.6 |
IDU | n/a | 7,009 | 17.5 | 215 | 15.1 | 186 | 13.4 | 183 | 13.3 | 225 | 16.2 | 216 | 15.1 | 8,034 | 17.1 |
Blood/blood productsFootnote ‡ | Recipient of blood/clotting factor | 166 | 0.4 | 0 | 0.0 | 1 | 0.1 | 1 | 0.1 | 0 | 0.0 | 1 | 0.1 | 169 | 0.4 |
Recipient of blood | 286 | 0.7 | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 | 1 | 0.1 | 1 | 0.1 | 289 | 0.6 | |
Recipient of clotting factor | 311 | 0.8 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 311 | 0.7 | |
Heterosexual contact | Origin from an HIV-endemic country | 2,824 | 7.0 | 172 | 12.1 | 129 | 9.3 | 136 | 9.9 | 149 | 10.7 | 151 | 10.5 | 3,561 | 7.6 |
Sexual contact with a person at risk | 2,939 | 7.3 | 145 | 10.2 | 159 | 11.4 | 130 | 9.4 | 118 | 8.5 | 127 | 8.9 | 3,618 | 7.7 | |
NIR-Het | 3,339 | 8.3 | 133 | 9.3 | 136 | 9.8 | 133 | 9.7 | 177 | 12.7 | 185 | 12.9 | 4,103 | 8.7 | |
OtherFootnote § | n/a | 445 | 1.1 | 63 | 4.4 | 70 | 5.0 | 87 | 6.3 | 54 | 3.9 | 66 | 4.6 | 785 | 1.7 |
Subtotal | n/a | 40,088 | 100 | 1,423 | 100 | 1,393 | 100 | 1,378 | 100 | 1,391 | 100 | 1,435 | 100 | 47,108 | 100 |
NIR | n/a | 3,555 | n/a | 64 | n/a | 36 | n/a | 70 | n/a | 58 | n/a | 87 | n/a | 3,870 | n/a |
Not reported | n/a | 25,946 | n/a | 568 | n/a | 606 | n/a | 593 | n/a | 637 | n/a | 806 | n/a | 29,156 | n/a |
TotalFootnote ¶ | n/a | 69,589 | n/a | 2,055 | n/a | 2,035 | n/a | 2,041 | n/a | 2,086 | n/a | 2,328 | n/a | 80,134 | n/a |
Exposure category | Exposure sub-category | Year of test | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote † | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
MSM | n/a | 21,641 | 66.0 | 665 | 61.7 | 674 | 61.8 | 669 | 63.0 | 624 | 59.3 | 633 | 59.0 | 24,906 | 65.3 |
MSM/IDU | n/a | 1,037 | 3.2 | 30 | 2.8 | 38 | 3.5 | 38 | 3.6 | 43 | 4.1 | 55 | 5.1 | 1,241 | 3.3 |
IDU | n/a | 4,546 | 13.9 | 129 | 12.0 | 121 | 11.1 | 102 | 9.6 | 131 | 12.5 | 117 | 10.9 | 5,146 | 13.5 |
Blood/blood productsFootnote ‡ | Recipient of blood/clotting factor | 128 | 0.4 | 0 | 0.0 | 1 | 0.1 | 1 | 0.1 | 0 | 0.0 | 1 | 0.1 | 131 | 0.3 |
Recipient of blood | 175 | 0.5 | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 | 1 | 0.1 | 1 | 0.1 | 178 | 0.5 | |
Recipient of clotting factor | 267 | 0.8 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 267 | 0.7 | |
Heterosexual contact | Origin from an HIV-endemic country | 1,234 | 3.8 | 60 | 5.6 | 46 | 4.2 | 60 | 5.6 | 54 | 5.1 | 66 | 6.2 | 1,520 | 4.0 |
Sexual contact with a person at risk | 1,409 | 4.3 | 66 | 6.1 | 80 | 7.3 | 65 | 6.1 | 51 | 4.8 | 60 | 5.6 | 1,731 | 4.5 | |
NIR-Het | 2,020 | 6.2 | 91 | 8.4 | 95 | 8.7 | 76 | 7.2 | 122 | 11.6 | 106 | 9.9 | 2,510 | 6.6 | |
OtherFootnote § | n/a | 311 | 0.9 | 37 | 3.4 | 35 | 3.2 | 50 | 4.7 | 26 | 2.5 | 33 | 3.1 | 492 | 1.3 |
Subtotal | n/a | 32,768 | 100 | 1,078 | 100 | 1,090 | 100 | 1,062 | 100 | 1,052 | 100 | 1,072 | 100 | 38,122 | 100 |
NIR | n/a | 2,761 | n/a | 49 | n/a | 31 | n/a | 46 | n/a | 48 | n/a | 69 | n/a | 3,004 | n/a |
Not reported | n/a | 20,525 | n/a | 447 | n/a | 470 | n/a | 435 | n/a | 484 | n/a | 640 | n/a | 23,001 | n/a |
TotalFootnote ¶ | n/a | 56,054 | n/a | 1,574 | n/a | 1,591 | n/a | 1,543 | n/a | 1,584 | n/a | 1,781 | n/a | 64,127 | n/a |
Exposure category | Exposure sub-category | Year of diagnosis | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1985-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote † | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
IDU | n/a | 2,412 | 33.8 | 86 | 24.9 | 64 | 21.3 | 79 | 25.3 | 94 | 27.7 | 99 | 27.3 | 2,834 | 32.2 |
Blood/blood productsFootnote ‡ | Recipient of blood/clotting factor | 38 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 38 | 0.4 |
Recipient of blood | 107 | 1.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 107 | 1.2 | |
Recipient of clotting factor | 31 | 0.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 31 | 0.4 | |
Heterosexual contact | Origin from an HIV-endemic country | 1,583 | 22.2 | 112 | 32.5 | 82 | 27.3 | 76 | 24.4 | 95 | 28.0 | 85 | 23.5 | 2,033 | 23.1 |
Sexual contact with a person at risk | 1,512 | 21.2 | 79 | 22.9 | 78 | 26.0 | 64 | 20.5 | 67 | 19.8 | 67 | 18.5 | 1,867 | 21.2 | |
NIR-Het | 1,319 | 18.5 | 42 | 12.2 | 41 | 13.7 | 56 | 17.9 | 55 | 16.2 | 78 | 21.5 | 1,591 | 18.1 | |
OtherFootnote § | n/a | 130 | 1.8 | 26 | 7.5 | 35 | 11.7 | 37 | 11.9 | 28 | 8.3 | 33 | 9.1 | 289 | 3.3 |
Subtotal | n/a | 7,132 | 100 | 345 | 100 | 300 | 100 | 312 | 100 | 339 | 100 | 362 | 100 | 8,790 | 100 |
NIR | n/a | 630 | n/a | 13 | n/a | 5 | n/a | 23 | n/a | 9 | n/a | 18 | n/a | 698 | n/a |
Not reported | n/a | 4,556 | n/a | 118 | n/a | 130 | n/a | 156 | n/a | 150 | n/a | 160 | n/a | 5,270 | n/a |
TotalFootnote ¶ | n/a | 12,318 | n/a | 476 | n/a | 435 | n/a | 491 | n/a | 498 | n/a | 540 | n/a | 14,758 | n/a |
Year | Exposure category | Exposure sub-category | Age group (years) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
15-19 | 20-29 | 30-39 | 40-49 | ≥ 50 | Age group not reported | Total | ||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | |||
2016 | MSM | n/a | 12 | 37.5 | 204 | 38.8 | 198 | 29.5 | 117 | 22.8 | 102 | 18.0 | 0 | 0 | 633 | 27.4 |
MSM/IDU | n/a | 2 | 6.3 | 15 | 2.9 | 20 | 3.0 | 10 | 1.9 | 8 | 1.4 | 0 | 0 | 55 | 2.4 | |
IDU | n/a | 4 | 12.5 | 49 | 9.3 | 77 | 11.5 | 46 | 8.9 | 40 | 7.0 | 0 | 0 | 216 | 9.3 | |
Blood/blood productsFootnote † | n/a | 0 | 0.0 | 1 | 0.2 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0 | 2 | 0.1 | |
Heterosexual contact | Origin from an HIV-endemic country | 3 | 9.4 | 23 | 4.4 | 49 | 7.3 | 44 | 8.6 | 32 | 5.6 | 0 | 0 | 151 | 6.5 | |
Sexual contact with a person at risk | 2 | 6.3 | 28 | 5.3 | 33 | 4.9 | 30 | 5.8 | 34 | 6.0 | 0 | 0 | 127 | 5.5 | ||
NIR-Het | 4 | 12.5 | 35 | 6.7 | 45 | 6.7 | 44 | 8.6 | 57 | 10.0 | 0 | 0 | 185 | 8.0 | ||
OtherFootnote ‡ | n/a | 5 | 15.6 | 11 | 2.1 | 21 | 3.1 | 18 | 3.5 | 11 | 1.9 | 0 | 0 | 66 | 2.9 | |
NIR | n/a | 0 | 0.0 | 11 | 2.1 | 20 | 3.0 | 27 | 5.3 | 27 | 4.8 | 0 | 0 | 85 | 3.7 | |
Not reported | n/a | 0 | 0.0 | 149 | 28.3 | 209 | 31.1 | 178 | 34.6 | 256 | 45.1 | 0 | 0 | 792 | 34.3 | |
2016 Total | n/a | 32 | 100 | 526 | 100 | 672 | 100 | 514 | 100 | 568 | 100 | 0 | 100 | 2,312 | 100 | |
2015 | MSM | n/a | 10 | 25.0 | 223 | 43.1 | 170 | 29.7 | 121 | 26.7 | 100 | 20.0 | 0 | 0 | 624 | 29.9 |
MSM/IDU | n/a | 0 | 0.0 | 17 | 3.3 | 13 | 2.3 | 6 | 1.3 | 7 | 1.4 | 0 | 0 | 43 | 2.1 | |
IDU | n/a | 4 | 10.0 | 60 | 11.6 | 66 | 11.5 | 63 | 13.9 | 32 | 6.4 | 0 | 0 | 225 | 10.8 | |
Blood/blood productsFootnote † | n/a | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.2 | 0 | 0 | 1 | 0.0 | |
Heterosexual contact | Origin from an HIV-endemic country | 5 | 12.5 | 21 | 4.1 | 47 | 8.2 | 41 | 9.0 | 35 | 7.0 | 0 | 0 | 149 | 7.1 | |
Sexual contact with a person at risk | 5 | 12.5 | 19 | 3.7 | 28 | 4.9 | 27 | 5.9 | 39 | 7.8 | 0 | 0 | 118 | 5.7 | ||
NIR-Het | 5 | 12.5 | 31 | 6.0 | 46 | 8.0 | 40 | 8.8 | 55 | 11.0 | 0 | 0 | 177 | 8.5 | ||
OtherFootnote ‡ | n/a | 1 | 2.5 | 14 | 2.7 | 16 | 2.8 | 12 | 2.6 | 11 | 2.2 | 0 | 0 | 54 | 2.6 | |
NIR | n/a | 1 | 2.5 | 10 | 1.9 | 16 | 2.8 | 14 | 3.1 | 17 | 3.4 | 0 | 0 | 58 | 2.8 | |
Not reported | n/a | 9 | 22.5 | 123 | 23.7 | 171 | 29.8 | 130 | 28.6 | 204 | 40.7 | 0 | 0 | 637 | 30.5 | |
2015 Total | n/a | 40 | 100 | 518 | 100 | 573 | 100 | 454 | 100 | 501 | 100 | 0 | 100 | 2,086 | 100 | |
Year | Exposure category | Exposure sub-category | Province/territory | Total | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BC | YT | AB | NT | NU | SK | MB | ON | QCFootnote † | NB | NS | PE | NL | n | %Footnote ‡ | |||
2016 | MSM | n/a | 133 | 0 | 87 | DS | DS | 7 | 24 | 362 | NR | 2 | 9 | DS | 6 | 633 | 44.0 |
MSM/IDU | n/a | 4 | 0 | 14 | DS | DS | 5 | 7 | 25 | NR | 0 | 0 | DS | 0 | 55 | 3.8 | |
IDU | n/a | 15 | 0 | 27 | DS | DS | 97 | 3 | 70 | NR | 2 | 2 | DS | 0 | 216 | 15.0 | |
Blood/blood productsFootnote § | n/a | 0 | 0 | 0 | DS | DS | 0 | 1 | 1 | NR | 0 | 0 | DS | 0 | 2 | 0.1 | |
Heterosexual contact | Origin from an HIV-endemic country | 0 | 1 | 32 | DS | DS | 8 | 27 | 82 | NR | 3 | 0 | DS | 0 | 153 | 10.6 | |
Sexual contact with a person at risk | 30 | 1 | 29 | DS | DS | 31 | 0 | 33 | NR | 0 | 1 | DS | 2 | 127 | 8.8 | ||
NIR-Het | 25 | 0 | 28 | DS | DS | 21 | 33 | 76 | NR | 0 | 2 | DS | 0 | 185 | 12.8 | ||
Other | n/a | 8 | 0 | 57 | DS | DS | 1 | 0 | 2 | NR | 0 | 0 | DS | 0 | 69 | 4.8 | |
2016 Subtotal | n/a | 215 | 2 | 274 | DS | DS | 170 | 95 | 651 | 0 | 7 | 14 | DS | 8 | 1,440 | 100 | |
NIR | n/a | 3 | 0 | 6 | DS | DS | 4 | 31 | 47 | 0 | 0 | 0 | DS | 0 | 91 | n/a | |
Not reported | n/a | 35 | 0 | 2 | DS | DS | 0 | 0 | 183 | 593 | 0 | 0 | DS | 0 | 813 | n/a | |
2016 Grand Total | n/a | 253 | 2 | 282 | DS | DS | 174 | 126 | 881 | 593 | 7 | 14 | DS | 8 | 2,344 | n/a | |
2015 | MSM | n/a | 132 | 1 | 66 | DS | DS | 12 | 34 | 355 | NR | 3 | 12 | DS | 7 | 624 | 44.6 |
MSM/IDU | n/a | 4 | 0 | 8 | DS | DS | 2 | 3 | 26 | NR | 0 | 0 | DS | 0 | 43 | 3.1 | |
IDU | n/a | 17 | 0 | 34 | DS | DS | 96 | 9 | 67 | NR | 0 | 1 | DS | 1 | 225 | 16.1 | |
Blood/blood productsFootnote § | n/a | 0 | 0 | 0 | DS | DS | 0 | 0 | 1 | NR | 0 | 0 | DS | 0 | 1 | 0.1 | |
Heterosexual contact | Origin from an HIV-endemic country | 0 | 0 | 29 | DS | DS | 5 | 22 | 92 | NR | 3 | 0 | DS | 0 | 151 | 10.8 | |
Sexual contact with a person at risk | 39 | 0 | 32 | DS | DS | 22 | 0 | 21 | NR | 2 | 1 | DS | 1 | 119 | 8.5 | ||
NIR-Het | 30 | 0 | 17 | DS | DS | 20 | 27 | 77 | NR | 1 | 3 | DS | 2 | 177 | 12.6 | ||
Other | 5 | 0 | 47 | DS | DS | 6 | 0 | 1 | NR | 0 | 0 | DS | 0 | 60 | 4.3 | ||
2015 Subtotal | n/a | 227 | 1 | 233 | DS | DS | 163 | 95 | 640 | 0 | 9 | 17 | DS | 11 | 1,400 | 100 | |
NIR | n/a | 3 | 0 | 2 | DS | DS | 2 | 10 | 42 | 0 | 0 | 0 | DS | 0 | 59 | n/a | |
Not reported | n/a | 9 | 0 | 2 | DS | DS | 0 | 0 | 157 | 473 | 0 | 0 | DS | 0 | 641 | n/a | |
2015 Grand Total | n/a | 239 | 1 | 237 | DS | DS | 165 | 105 | 839 | 473 | 9 | 17 | DS | 11 | 2,100 | n/a | |
Race/ethnicity | Race/ethnicity sub-category | Year of test | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1998-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote § | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
Indigenous | First Nations | 1,401 | 19.8 | 174 | 15.9 | 131 | 12.6 | 142 | 13.9 | 167 | 15.4 | 217 | 19.0 | 2,232 | 17.9 |
Métis | 187 | 2.6 | 13 | 1.2 | 11 | 1.1 | 27 | 2.6 | 27 | 2.5 | 18 | 1.6 | 283 | 2.3 | |
Inuit | 14 | 0.2 | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 3 | 0.3 | 18 | 0.1 | |
Indigenous, unspecified | 438 | 6.2 | 34 | 3.1 | 57 | 5.5 | 1 | 0.1 | 9 | 0.8 | 4 | 0.4 | 543 | 4.4 | |
South Asian/West Asian/ArabFootnote ¶ | n/a | 93 | 1.3 | 43 | 3.9 | 31 | 3.0 | 36 | 3.5 | 40 | 3.7 | 44 | 3.9 | 287 | 2.3 |
AsianFootnote ‖ | n/a | 225 | 3.2 | 50 | 4.6 | 54 | 5.2 | 59 | 5.8 | 74 | 6.8 | 66 | 5.8 | 528 | 4.2 |
BlackFootnote ** | n/a | 1,243 | 17.6 | 285 | 26.1 | 208 | 19.9 | 237 | 23.1 | 225 | 20.8 | 250 | 21.9 | 2,448 | 19.7 |
Latin AmericanFootnote †† | n/a | 170 | 2.4 | 37 | 3.4 | 57 | 5.5 | 55 | 5.4 | 48 | 4.4 | 55 | 4.8 | 422 | 3.4 |
White | n/a | 3,241 | 45.8 | 437 | 40.0 | 479 | 45.9 | 441 | 43.0 | 470 | 43.5 | 460 | 40.4 | 5,528 | 44.4 |
Other | n/a | 59 | 0.8 | 20 | 1.8 | 15 | 1.4 | 26 | 2.5 | 21 | 1.9 | 23 | 2.0 | 164 | 1.3 |
Subtotal | n/a | 7,071 | 100 | 1,093 | 100 | 1,043 | 100 | 1,025 | 100 | 1,081 | 100 | 1,140 | 100 | 12,453 | 100 |
Not reported | n/a | 25,897 | n/a | 980 | n/a | 1,017 | n/a | 1,028 | n/a | 1,019 | n/a | 1,204 | n/a | 31,145 | n/a |
Total | n/a | 32,968 | n/a | 2,073 | n/a | 2,060 | n/a | 2,053 | n/a | 2,100 | n/a | 2,344 | n/a | 43,598 | n/a |
Race/ethnicity | Race/ethnicity sub-category | Year of test | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1998-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote § | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
Indigenous | First Nations | 689 | 14.1 | 106 | 13.4 | 74 | 9.3 | 76 | 9.9 | 91 | 11.5 | 113 | 13.7 | 1,149 | 13.0 |
Métis | 106 | 2.2 | 4 | 0.5 | 11 | 1.4 | 16 | 2.1 | 18 | 2.3 | 11 | 1.3 | 166 | 1.9 | |
Inuit | 10 | 0.2 | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 | 0 | 0.0 | 2 | 0.2 | 13 | 0.1 | |
Indigenous, unspecified | 236 | 4.8 | 17 | 2.1 | 30 | 3.8 | 0 | 0.0 | 3 | 0.4 | 1 | 0.1 | 287 | 3.2 | |
South Asian/West Asian/ArabFootnote ¶ | n/a | 83 | 1.7 | 37 | 4.7 | 27 | 3.4 | 30 | 3.9 | 35 | 4.4 | 37 | 4.5 | 249 | 2.8 |
AsianFootnote ‖ | n/a | 177 | 3.6 | 45 | 5.7 | 53 | 6.7 | 52 | 6.8 | 69 | 8.7 | 62 | 7.5 | 458 | 5.2 |
BlackFootnote ** | n/a | 605 | 12.4 | 142 | 17.9 | 103 | 12.9 | 137 | 17.9 | 104 | 13.1 | 135 | 16.4 | 1,226 | 13.8 |
Latin AmericanFootnote †† | n/a | 152 | 3.1 | 36 | 4.5 | 53 | 6.7 | 50 | 6.5 | 43 | 5.4 | 52 | 6.3 | 386 | 4.4 |
White | n/a | 2,784 | 57.0 | 390 | 49.1 | 431 | 54.1 | 382 | 49.8 | 411 | 51.8 | 394 | 47.8 | 4,792 | 54.1 |
Other | n/a | 46 | 0.9 | 17 | 2.1 | 14 | 1.8 | 23 | 3.0 | 19 | 2.4 | 17 | 2.1 | 136 | 1.5 |
Subtotal | n/a | 4,888 | 100 | 794 | 100 | 796 | 100 | 767 | 100 | 793 | 100 | 824 | 100 | 8,862 | 100 |
Not reported | n/a | 19,644 | n/a | 790 | n/a | 807 | n/a | 781 | n/a | 796 | n/a | 964 | n/a | 23,782 | n/a |
TotalFootnote ‡‡ | n/a | 24,532 | n/a | 1,584 | n/a | 1,603 | n/a | 1,548 | n/a | 1,589 | n/a | 1,788 | n/a | 32,644 | n/a |
Race/ethnicity | Race/ethnicity sub-category | Year of test | Total | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1998-2011 | 2012 | 2013 | 2014 | 2015 | 2016 | n | %Footnote § | ||||||||
n | % | n | % | n | % | n | % | n | % | n | % | ||||
Indigenous | First Nations | 712 | 32.7 | 68 | 22.9 | 57 | 23.3 | 66 | 25.7 | 76 | 26.6 | 103 | 32.7 | 1,082 | 30.2 |
Métis | 81 | 3.7 | 9 | 3.0 | 0 | 0.0 | 11 | 4.3 | 9 | 3.1 | 7 | 2.2 | 117 | 3.3 | |
Inuit | 4 | 0.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.3 | 5 | 0.1 | |
Indigenous, unspecified | 202 | 9.3 | 17 | 5.7 | 27 | 11.0 | 1 | 0.4 | 6 | 2.1 | 3 | 1.0 | 256 | 7.2 | |
South Asian/West Asian/ArabFootnote ‖ | n/a | 10 | 0.5 | 6 | 2.0 | 4 | 1.6 | 6 | 2.3 | 5 | 1.7 | 7 | 2.2 | 38 | 1.1 |
AsianFootnote ** | n/a | 48 | 2.2 | 5 | 1.7 | 1 | 0.4 | 7 | 2.7 | 4 | 1.4 | 4 | 1.3 | 69 | 1.9 |
BlackFootnote †† | n/a | 637 | 29.2 | 143 | 48.1 | 104 | 42.4 | 100 | 38.9 | 121 | 42.3 | 115 | 36.5 | 1,220 | 34.1 |
Latin AmericanFootnote ‡‡ | n/a | 18 | 0.8 | 1 | 0.3 | 4 | 1.6 | 5 | 1.9 | 5 | 1.7 | 3 | 1.0 | 36 | 1.0 |
White | n/a | 455 | 20.9 | 46 | 15.5 | 47 | 19.2 | 58 | 22.6 | 58 | 20.3 | 66 | 21.0 | 730 | 20.4 |
Other | n/a | 13 | 0.6 | 2 | 0.7 | 1 | 0.4 | 3 | 1.2 | 2 | 0.7 | 6 | 1.9 | 27 | 0.8 |
Subtotal | n/a | 2,180 | 100 | 297 | 100 | 245 | 100 | 257 | 100 | 286 | 100 | 315 | 100 | 3,580 | 100 |
Not reported | n/a | 6,005 | n/a | 186 | n/a | 201 | n/a | 240 | n/a | 219 | n/a | 232 | n/a | 7,083 | n/a |
TotalFootnote ¶¶ | n/a | 8,185 | n/a | 483 | n/a | 446 | n/a | 497 | n/a | 505 | n/a | 547 | n/a | 10,663 | n/a |
Year | Race/ethnicity | Race/ethnicity sub-category | MSM | MSM/IDU | IDU | Blood/blood products | Heterosexual contact | Perinatal trans-mission | Other | NIR | Not reported | Total | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Origin from an HIV-endemic country | Sexual contact with a person at risk | NIR-Het | ||||||||||||
2016 | Indigenous | First Nations | 18 | 12 | 96 | 1 | 0 | 35 | 48 | 0 | 0 | 7 | 0 | 217 |
Métis | 2 | 1 | 11 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 18 | ||
Inuit | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | ||
Indigenous, unspecified | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 4 | ||
South Asian/West Asian/ArabFootnote ‖ | n/a | 31 | 0 | 0 | 0 | 1 | 3 | 5 | 0 | 3 | 1 | 0 | 44 | |
AsianFootnote ** | n/a | 43 | 1 | 0 | 0 | 2 | 4 | 11 | 0 | 4 | 1 | 0 | 66 | |
BlackFootnote †† | n/a | 43 | 2 | 3 | 1 | 133 | 7 | 18 | 0 | 41 | 1 | 1 | 250 | |
Latin AmericanFootnote ‡‡ | n/a | 43 | 2 | 0 | 0 | 1 | 3 | 3 | 0 | 2 | 1 | 0 | 55 | |
White | n/a | 252 | 31 | 69 | 0 | 2 | 35 | 55 | 0 | 3 | 12 | 1 | 460 | |
Other | n/a | 9 | 1 | 2 | 0 | 2 | 3 | 2 | 0 | 2 | 2 | 0 | 23 | |
Subtotal 2016 | n/a | 443 | 50 | 183 | 2 | 141 | 92 | 146 | 0 | 55 | 26 | 2 | 1,140 | |
Not reported | n/a | 190 | 5 | 33 | 0 | 12 | 35 | 39 | 3 | 11 | 65 | 811 | 1,204 | |
Total 2016 | n/a | 633 | 55 | 216 | 2 | 153 | 127 | 185 | 3 | 66 | 91 | 813 | 2,344 | |
2015 | Indigenous | First Nations | 8 | 2 | 94 | 0 | 0 | 30 | 24 | 3 | 3 | 2 | 1 | 167 |
Métis | 6 | 0 | 14 | 0 | 0 | 2 | 5 | 0 | 0 | 0 | 0 | 27 | ||
Inuit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Indigenous, unspecified | 0 | 0 | 4 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 9 | ||
South Asian/West Asian/ArabFootnote ‖ | n/a | 21 | 0 | 5 | 0 | 1 | 3 | 9 | 0 | 0 | 1 | 0 | 40 | |
AsianFootnote ** | n/a | 50 | 2 | 1 | 0 | 6 | 1 | 7 | 0 | 5 | 2 | 0 | 74 | |
BlackFootnote †† | n/a | 36 | 4 | 0 | 1 | 127 | 6 | 16 | 0 | 33 | 1 | 1 | 225 | |
Latin AmericanFootnote ‡‡ | n/a | 26 | 1 | 2 | 0 | 1 | 2 | 10 | 0 | 4 | 2 | 0 | 48 | |
White | n/a | 281 | 24 | 68 | 0 | 0 | 32 | 53 | 0 | 2 | 9 | 1 | 470 | |
Other | n/a | 14 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 2 | 0 | 0 | 21 | |
Subtotal 2015 | n/a | 442 | 33 | 188 | 1 | 135 | 76 | 134 | 3 | 49 | 17 | 3 | 1,081 | |
Not reported | n/a | 182 | 10 | 37 | 0 | 16 | 43 | 43 | 2 | 6 | 42 | 638 | 1,019 | |
Total 2015 | n/a | 624 | 43 | 225 | 1 | 151 | 119 | 177 | 5 | 55 | 59 | 641 | 2,100 | |
2014 | Indigenous | First Nations | 10 | 5 | 69 | 0 | 0 | 27 | 23 | 0 | 4 | 3 | 1 | 142 |
Métis | 2 | 0 | 14 | 0 | 0 | 6 | 2 | 0 | 2 | 1 | 0 | 27 | ||
Inuit | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||
Indigenous, unspecified | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | ||
South Asian/West Asian/ArabFootnote ‖ | n/a | 16 | 0 | 1 | 0 | 3 | 5 | 9 | 0 | 0 | 2 | 0 | 36 | |
AsianFootnote ** | n/a | 45 | 0 | 0 | 0 | 2 | 0 | 5 | 0 | 7 | 0 | 0 | 59 | |
BlackFootnote †† | n/a | 48 | 3 | 3 | 1 | 115 | 10 | 5 | 0 | 50 | 2 | 0 | 237 | |
Latin AmericanFootnote ‡‡ | n/a | 36 | 3 | 1 | 0 | 2 | 2 | 6 | 0 | 3 | 2 | 0 | 55 | |
White | n/a | 272 | 24 | 53 | 0 | 2 | 35 | 32 | 0 | 12 | 10 | 1 | 441 | |
Other | n/a | 16 | 0 | 1 | 0 | 2 | 3 | 2 | 0 | 2 | 0 | 0 | 26 | |
Subtotal 2014 | n/a | 446 | 35 | 142 | 1 | 126 | 89 | 84 | 0 | 80 | 20 | 2 | 1,025 | |
Not reported | n/a | 223 | 4 | 41 | 1 | 13 | 41 | 49 | 1 | 8 | 50 | 597 | 1,028 | |
Total 2014 | n/a | 669 | 39 | 183 | 2 | 139 | 130 | 133 | 1 | 88 | 70 | 599 | 2,053 | |
2013 | Indigenous | First Nations | 7 | 2 | 72 | 0 | 0 | 27 | 16 | 0 | 3 | 3 | 1 | 131 |
Métis | 0 | 1 | 4 | 0 | 0 | 2 | 4 | 0 | 0 | 0 | 0 | 11 | ||
Inuit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Indigenous, unspecified | 8 | 0 | 16 | 0 | 0 | 28 | 3 | 0 | 1 | 1 | 0 | 57 | ||
South Asian/West Asian/ArabFootnote ‖ | n/a | 19 | 1 | 0 | 0 | 0 | 4 | 5 | 0 | 0 | 2 | 0 | 31 | |
AsianFootnote ** | n/a | 46 | 2 | 0 | 0 | 2 | 3 | 0 | 0 | 1 | 0 | 0 | 54 | |
BlackFootnote †† | n/a | 33 | 0 | 3 | 0 | 105 | 6 | 11 | 1 | 49 | 0 | 0 | 208 | |
Latin AmericanFootnote ‡‡ | n/a | 46 | 0 | 0 | 0 | 1 | 4 | 3 | 0 | 2 | 1 | 0 | 57 | |
White | n/a | 308 | 22 | 51 | 0 | 2 | 42 | 40 | 0 | 8 | 6 | 0 | 479 | |
Other | n/a | 8 | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 2 | 0 | 0 | 15 | |
Subtotal 2013 | n/a | 475 | 29 | 147 | 0 | 110 | 117 | 84 | 1 | 66 | 13 | 1 | 1,043 | |
Not reported | n/a | 200 | 9 | 39 | 1 | 20 | 42 | 52 | 4 | 9 | 25 | 616 | 1,017 | |
Total 2013 | n/a | 675 | 38 | 186 | 1 | 130 | 159 | 136 | 5 | 75 | 38 | 617 | 2,060 | |
2012 | Indigenous | First Nations | 11 | 3 | 104 | 0 | 0 | 27 | 21 | 0 | 5 | 3 | 0 | 174 |
Métis | 2 | 0 | 9 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 13 | ||
Inuit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Indigenous, unspecified | 3 | 1 | 9 | 0 | 0 | 20 | 0 | 0 | 0 | 1 | 0 | 34 | ||
South Asian/West Asian/ArabFootnote ‖ | n/a | 19 | 1 | 1 | 0 | 1 | 5 | 10 | 1 | 0 | 5 | 0 | 43 | |
AsianFootnote ** | n/a | 36 | 0 | 0 | 0 | 1 | 6 | 5 | 0 | 1 | 1 | 0 | 50 | |
BlackFootnote †† | n/a | 50 | 3 | 3 | 0 | 160 | 11 | 12 | 0 | 44 | 2 | 0 | 285 | |
Latin AmericanFootnote ‡‡ | n/a | 29 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 3 | 2 | 0 | 37 | |
White | n/a | 290 | 13 | 45 | 0 | 1 | 37 | 37 | 0 | 4 | 10 | 0 | 437 | |
Other | n/a | 13 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 3 | 0 | 20 | |
Subtotal 2012 | n/a | 453 | 22 | 171 | 0 | 165 | 107 | 90 | 1 | 57 | 27 | 0 | 1,093 | |
Not reported | n/a | 212 | 8 | 45 | 0 | 9 | 38 | 43 | 0 | 7 | 37 | 581 | 980 | |
Total 2012 | n/a | 665 | 30 | 216 | 0 | 174 | 145 | 133 | 1 | 64 | 64 | 581 | 2,073 | |
1998 - 2011 | Indigenous | First Nations | 46 | 37 | 905 | 2 | 2 | 211 | 143 | 11 | 5 | 20 | 19 | 1,401 |
Métis | 10 | 9 | 125 | 1 | 0 | 22 | 14 | 1 | 0 | 3 | 2 | 187 | ||
Inuit | 3 | 0 | 3 | 0 | 1 | 2 | 5 | 0 | 0 | 0 | 0 | 14 | ||
Indigenous, unspecified | 33 | 9 | 149 | 7 | 0 | 202 | 5 | 1 | 1 | 31 | 0 | 438 | ||
South Asian/West Asian/ArabFootnote ‖ | n/a | 49 | 1 | 1 | 2 | 7 | 12 | 11 | 0 | 0 | 10 | 0 | 93 | |
AsianFootnote ** | n/a | 119 | 4 | 2 | 0 | 25 | 26 | 42 | 0 | 3 | 4 | 0 | 225 | |
BlackFootnote †† | n/a | 113 | 3 | 26 | 3 | 933 | 46 | 51 | 6 | 45 | 11 | 6 | 1,243 | |
Latin AmericanFootnote ‡‡ | n/a | 123 | 1 | 2 | 1 | 8 | 15 | 14 | 0 | 3 | 2 | 1 | 170 | |
White | n/a | 1,669 | 102 | 608 | 17 | 14 | 397 | 318 | 5 | 21 | 70 | 20 | 3,241 | |
Other | n/a | 27 | 0 | 10 | 0 | 5 | 4 | 9 | 1 | 2 | 0 | 1 | 59 | |
Subtotal 1998-2011 | n/a | 2,192 | 166 | 1,831 | 33 | 995 | 937 | 1,836 | 25 | 80 | 151 | 49 | 7,071 | |
Not reported | n/a | 6,423 | 394 | 2,416 | 55 | 1,618 | 1,141 | 1,836 | 98 | 71 | 946 | 10,899 | 25,897 | |
Total 1998-2011 | n/a | 8,615 | 560 | 4,247 | 88 | 2,613 | 2,078 | 3,672 | 123 | 151 | 1,097 | 10,948 | 32,968 | |
Total all years | n/a | 11,881 | 765 | 5,273 | 94 | 3,360 | 2,758 | 4,436 | 138 | 499 | 1,419 | 14,199 | 43,598 | |
YearFootnote † | Tested in CanadaFootnote * | Tested overseas | ||
---|---|---|---|---|
Number diagnosed with HIV | % | Number diagnosed with HIV | % | |
2002 | 265 | n/a | NR | n/a |
2003 | 366 | n/a | NR | n/a |
2004 | 329 | n/a | NR | n/a |
2005 | 282 | 65.4 | 149 | 34.6 |
2006 | 373 | 69.9 | 161 | 30.1 |
2007 | 308 | 73.5 | 111 | 26.5 |
2008 | 365 | 66.6 | 183 | 33.4 |
2009 | 275 | 76.6 | 84 | 23.4 |
2010 | 231 | 67.5 | 111 | 32.5 |
2011 | 210 | 63.8 | 119 | 36.2 |
2012 | 243 | 63.4 | 140 | 36.6 |
2013 | 422 | 67.7 | 201 | 32.3 |
2014 | 345 | 67.9 | 163 | 32.1 |
2015 | 350 | 63.6 | 200 | 36.4 |
Total | 4,364 | 72.9 | 1,622 | 27.1 |
Demographic | Tested in CanadaFootnote * | Tested overseasFootnote * | ||
---|---|---|---|---|
Number diagnosed with HIV | % | Number diagnosed with HIV | % | |
Sex | ||||
Male | 2,493 | 57.1 | 788 | 48.6 |
Female | 1,870 | 42.9 | 834 | 51.4 |
Age group | ||||
<20 | 79 | 1.8 | 141 | 8.7 |
20-29 | 970 | 22.2 | 411 | 25.3 |
30-39 | 1,829 | 41.9 | 649 | 40.0 |
40-49 | 1,090 | 25.0 | 311 | 19.2 |
50+ | 396 | 9.1 | 110 | 6.8 |
ProvinceFootnote † | ||||
Alberta | 330 | 7.6 | 232 | 14.4 |
British Columbia | 380 | 8.7 | 209 | 12.9 |
Manitoba | 90 | 2.1 | 140 | 8.7 |
Ontario | 2,386 | 54.7 | 540 | 33.4 |
Quebec | 1,098 | 25.2 | 404 | 25.0 |
Saskatchewan | 42 | 1.0 | 46 | 2.8 |
Atlantic provincesFootnote ‡ | 37 | 0.8 | 45 | 2.8 |
HIV-endemic country | ||||
Yes | 2,937 | 67.3 | 1,170 | 72.1 |
No | 1,427 | 32.7 | 452 | 27.9 |
ART use | Status | Year of birth | Total | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1984-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | |||
No perinatal ART prophylaxis | Confirmed infected | ||||||||||
Asymptomatic | 74 | 6 | 6 | 5 | 1 | 2 | 0 | 2 | 1 | 97 | |
Symptomatic | 22 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 24 | |
Died of AIDS | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | |
Died of other | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | |
Lost to follow-upFootnote * | 170 | 3 | 1 | 0 | 0 | 1 | 0 | 2 | 0 | 177 | |
Adult careFootnote † | 216 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 216 | |
Subtotal confirmed infected | 592 | 9 | 8 | 5 | 1 | 3 | 0 | 5 | 1 | 624 | |
Subtotal confirmed not infected | 481 | 17 | 11 | 7 | 9 | 5 | 7 | 6 | 8 | 551 | |
Infection status not confirmed | |||||||||||
Indeterminate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Lost to follow-up | 23 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 25 | |
Subtotal Infection status not confirmed | 23 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 26 | |
Total ‘No perinatal ART prophylaxis’ | 1,096 | 26 | 19 | 13 | 11 | 8 | 7 | 11 | 10 | 1,201 | |
Any perinatal ART prophylaxis | Confirmed infected | ||||||||||
Asymptomatic | 2 | 0 | 3 | 2 | 0 | 0 | 2 | 1 | 0 | 10 | |
Symptomatic | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | |
Died of AIDS | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Died of other | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Lost to follow-upFootnote * | 9 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | |
Adult careFootnote † | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | |
Subtotal confirmed infected | 20 | 1 | 4 | 3 | 0 | 0 | 2 | 1 | 0 | 31 | |
Subtotal confirmed not infected | 1,789 | 172 | 222 | 216 | 216 | 198 | 238 | 230 | 226 | 3,507 | |
Infection status not confirmed | |||||||||||
Indeterminate | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24 | 24 | |
Lost to follow-up | 22 | 1 | 1 | 1 | 1 | 0 | 0 | 4 | 1 | 31 | |
Subtotal Infection status not confirmed | 22 | 1 | 1 | 1 | 1 | 0 | 0 | 4 | 25 | 55 | |
Total ‘Any perinatal ART prophylaxis | 1,831 | 174 | 227 | 220 | 217 | 198 | 240 | 235 | 251 | 3,593 | |
Perinatal ART prophylaxis exposure unknown | Total ‘Perinatal ART prophylaxis exposure unknown’ | 35 | 3 | 4 | 4 | 1 | 2 | 2 | 2 | 2 | 55 |
Grand Total | 2,962 | 203 | 250 | 237 | 229 | 208 | 249 | 248 | 263 | 4,849 | |
Maternal exposure category | Year of birth | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1984-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | Total | |||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | %Footnote * | |
IDU | 660 | 24.6 | 31 | 16.8 | 43 | 19.2 | 47 | 21.2 | 34 | 16.6 | 34 | 18.0 | 48 | 20.7 | 54 | 23.9 | 50 | 22.3 | 1,001 | 22.8 |
Blood products/ transfusion/ medical | 44 | 1.6 | 5 | 2.7 | 5 | 2.2 | 1 | 0.5 | 3 | 1.5 | 8 | 4.2 | 5 | 2.2 | 5 | 2.2 | 2 | 0.9 | 78 | 1.8 |
Heterosexual contact | 1,962 | 73.0 | 144 | 78.3 | 173 | 77.2 | 174 | 78.4 | 165 | 80.5 | 143 | 75.7 | 167 | 72.0 | 153 | 67.7 | 159 | 71.0 | 3,240 | 73.8 |
Mother-to-childFootnote † | 6 | 0.2 | 3 | 1.6 | 3 | 1.3 | 0 | 0.0 | 3 | 1.5 | 3 | 1.6 | 6 | 2.6 | 12 | 5.3 | 8 | 3.6 | 44 | 1.0 |
Other | 15 | 0.6 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 6 | 2.6 | 2 | 0.9 | 5 | 2.2 | 30 | 0.7 |
NIR | 275 | n/a | 19 | n/a | 26 | n/a | 15 | n/a | 24 | n/a | 19 | n/a | 17 | n/a | 22 | n/a | 39 | n/a | 456 | n/a |
Total | 2,962 | 100 | 203 | 100 | 250 | 100 | 237 | 1 | 229 | 100 | 208 | 100 | 249 | 100 | 248 | 100 | 263 | 100 | 4,849 | 100 |
Race/ethnicity | Infection Status | Year of birth | Total | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1984-1996 | 1997-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||
White | Prospective cohortFootnote * | ||||||||||||||||||||||
Confirmed infected | 29 | 16.4 | 9 | 1.8 | 0 | 0.0 | 4 | 8.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 42 | 4.2 | |
Confirmed not infected | 148 | 83.6 | 485 | 98.2 | 29 | 100 | 46 | 92.0 | 36 | 100 | 39 | 100.0 | 37 | 100 | 60 | 100 | 48 | 100 | 27 | 100 | 955 | 95.8 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 76 | 69.7 | 9 | 50.0 | 2 | 100 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 88 | 66.7 | |
Confirmed not infected | 33 | 30.3 | 9 | 50.0 | 0 | 0.0 | 1 | 100 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 44 | 33.3 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 9 | n/a | 8 | n/a | 1 | n/a | 0 | n/a | 0 | n/a | 1 | n/a | 0 | n/a | 0 | n/a | 1 | n/a | 4 | n/a | 24 | n/a | |
Subtotal White | 295 | 36.7 | 520 | 24.1 | 32 | 15.8 | 51 | 20.4 | 38 | 16.0 | 40 | 17.5 | 37 | 17.8 | 60 | 24.1 | 49 | 19.8 | 31 | 11.8 | 1,153 | 23.8 | |
BlackFootnote ‡ | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 32 | 21.3 | 21 | 2.4 | 1 | 0.9 | 0 | 0.0 | 3 | 2.5 | 0 | 0.0 | 0 | 0.0 | 1 | 0.8 | 0 | 0.0 | 0 | 0.0 | 58 | 2.9 | |
Confirmed not infected | 118 | 78.7 | 848 | 97.6 | 107 | 99.1 | 119 | 100 | 118 | 97.5 | 136 | 100.0 | 107 | 100 | 126 | 99.2 | 111 | 100 | 119 | 100.0 | 1,909 | 97.1 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 170 | 85.4 | 165 | 81.3 | 3 | 75.0 | 4 | 100 | 3 | 100 | 1 | 33.3 | 2 | 100 | 0 | 0.0 | 1 | 100 | 1 | 50.0 | 350 | 83.1 | |
Confirmed not infected | 29 | 14.6 | 38 | 18.7 | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 2 | 66.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 50.0 | 71 | 16.9 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 7 | n/a | 6 | n/a | 1 | n/a | 0 | n/a | 2 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 2 | n/a | 7 | n/a | 25 | n/a | |
Subtotal Black | 356 | 44.3 | 1078 | 50.0 | 113 | 55.7 | 123 | 49.2 | 126 | 53.2 | 139 | 60.7 | 109 | 52.4 | 127 | 51.0 | 114 | 46.0 | 128 | 48.7 | 2,413 | 49.8 | |
Latin AmericanFootnote § | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 5 | 71.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 10.6 | |
Confirmed not infected | 2 | 28.6 | 17 | 100 | 5 | 100 | 0 | 0.0 | 5 | 100 | 3 | 100.0 | 0 | 0.0 | 1 | 100.0 | 5 | 100.0 | 4 | 100 | 42 | 89.4 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 4 | 100.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 83.3 | |
Confirmed not infected | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 16.7 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 0 | n/a | 3 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 3 | n/a | |
Subtotal Latin American | 11 | 1.4 | 22 | 1.0 | 5 | 2.5 | 0 | 0.0 | 5 | 2.1 | 3 | 1.3 | 0 | 0.0 | 1 | 0.4 | 5 | 2.0 | 4 | 1.5 | 56 | 1.2 | |
AboriginalFootnote ¶ | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 11 | 21.6 | 17 | 4.6 | 0 | 0.0 | 2 | 4.0 | 0 | 0.0 | 0 | 0.0 | 1 | 2.0 | 0 | 0.0 | 5 | 8.5 | 0 | 0.0 | 36 | 4.5 | |
Confirmed not infected | 40 | 78.4 | 351 | 95.4 | 37 | 100 | 48 | 96.0 | 49 | 100 | 35 | 100 | 50 | 98.0 | 47 | 100 | 54 | 91.5 | 56 | 100 | 767 | 95.5 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 14 | 63.6 | 6 | 46.2 | 1 | 33.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 21 | 55.3 | |
Confirmed not infected | 8 | 36.4 | 7 | 53.8 | 2 | 66.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 17 | 44.7 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 3 | n/a | 6 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 1 | n/a | 0 | n/a | 0 | n/a | 1 | n/a | 11 | n/a | 22 | n/a | |
Subtotal Aboriginal | 76 | 9.5 | 387 | 17.9 | 40 | 19.7 | 50 | 20.0 | 49 | 20.7 | 36 | 15.7 | 51 | 24.5 | 47 | 18.9 | 60 | 24.2 | 67 | 25.5 | 863 | 17.8 | |
AsianFootnote ‖ | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 0 | 0.0 | 2 | 3.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 1.6 | |
Confirmed not infected | 7 | 100 | 58 | 96.7 | 6 | 100 | 9 | 100 | 6 | 100 | 6 | 100 | 5 | 100.0 | 6 | 100 | 8 | 100 | 13 | 100 | 124 | 98.4 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 15 | 88.2 | 12 | 75.0 | 3 | 100.0 | 4 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 34 | 79.1 | |
Confirmed not infected | 2 | 11.8 | 4 | 25.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 100.0 | 1 | 100.0 | 0 | 0.0 | 9 | 20.9 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | |
Subtotal Asian | 24 | 3.0 | 76 | 3.5 | 9 | 4.4 | 13 | 5.2 | 6 | 2.5 | 6 | 2.6 | 5 | 2.4 | 8 | 3.2 | 9 | 3.6 | 13 | 4.9 | 169 | 3.5 | |
OtherFootnote ** | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 1.4 | |
Confirmed not infected | 3 | 75.0 | 25 | 100.0 | 1 | 100.0 | 6 | 100.0 | 8 | 100.0 | 5 | 100.0 | 5 | 100.0 | 4 | 100.0 | 4 | 100.0 | 7 | 100.0 | 68 | 98.6 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 3 | 50.0 | 3 | 60.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 7 | 58.3 | |
Confirmed not infected | 3 | 50.0 | 2 | 40.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 41.7 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | |
Subtotal Other | 10 | 1.2 | 30 | 1.4 | 1 | 0.5 | 7 | 2.8 | 8 | 3.4 | 5 | 2.2 | 5 | 2.4 | 4 | 1.6 | 4 | 1.6 | 7 | 2.7 | 81 | 1.7 | |
Unknown | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 100.0 | 2 | 7.1 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 4 | 7.1 | |
Confirmed not infected | 0 | 0.0 | 26 | 92.9 | 1 | 50.0 | 5 | 100.0 | 3 | 100.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 7 | 100.0 | 9 | 100.0 | 52 | 92.9 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 10 | 33.3 | 15 | 100.0 | 1 | 100.0 | 0 | 0.0 | 2 | 100.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 29 | 58.0 | |
Confirmed not infected | 20 | 66.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 21 | 42.0 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 1 | n/a | 2 | n/a | 0 | n/a | 1 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 4 | n/a | 8 | n/a | |
Subtotal Unknown | 32 | 4.0 | 45 | 2.1 | 3 | 1.5 | 6 | 2.4 | 5 | 2.1 | 0 | 0.0 | 1 | 0.5 | 2 | 0.8 | 7 | 2.8 | 13 | 4.9 | 114 | 2.4 | |
Total ethnicities | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 79 | 19.9 | 51 | 2.7 | 2 | 1.1 | 6 | 2.5 | 3 | 1.3 | 0 | 0.0 | 1 | 0.5 | 1 | 0.4 | 5 | 2.1 | 0 | 0.0 | 148 | 3.6 | |
Confirmed not infected | 318 | 80.1 | 1,810 | 97.3 | 186 | 98.9 | 233 | 97.5 | 225 | 98.7 | 224 | 100.0 | 204 | 99.5 | 245 | 99.6 | 237 | 97.9 | 235 | 100.0 | 3,917 | 96.4 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 292 | 75.5 | 211 | 77.6 | 10 | 76.9 | 9 | 90.0 | 6 | 85.7 | 1 | 33.3 | 2 | 66.7 | 1 | 33.3 | 1 | 50.0 | 1 | 50.0 | 534 | 76.1 | |
Confirmed not infected | 95 | 24.5 | 61 | 22.4 | 3 | 23.1 | 1 | 10.0 | 1 | 14.3 | 2 | 66.7 | 1 | 33.3 | 2 | 66.7 | 1 | 50.0 | 1 | 50.0 | 168 | 23.9 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 20 | n/a | 25 | n/a | 2 | n/a | 1 | n/a | 2 | n/a | 2 | n/a | 0 | n/a | 0 | n/a | 4 | n/a | 26 | n/a | 82 | n/a | |
Grand total | 804 | 100.0 | 2,158 | 100.0 | 203 | 100.0 | 250 | 100.0 | 237 | 100.0 | 229 | 100.0 | 208 | 100.0 | 249 | 100.0 | 248 | 100.0 | 263 | 100.0 | 4,849 | 100.0 | |
Country of birth | Infection status | Year of birth | Total | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1984-1996 | 1997-2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||||
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | ||
North America | Prospective cohortFootnote * | ||||||||||||||||||||||
Confirmed infected | 41 | 17.4 | 25 | 2.8 | 1 | 1.5 | 6 | 5.6 | 0 | 0.0 | 0 | 0.0 | 1 | 1.1 | 0 | 0.0 | 5 | 4.5 | 0 | 0.0 | 79 | 4.2 | |
Confirmed not infected | 195 | 82.6 | 867 | 97.2 | 67 | 98.5 | 102 | 94.4 | 90 | 100.0 | 74 | 100.0 | 89 | 98.9 | 107 | 100.0 | 105 | 95.5 | 88 | 100.0 | 1,784 | 95.8 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 73 | 67.0 | 15 | 48.4 | 2 | 50.0 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 91 | 62.3 | |
Confirmed not infected | 36 | 33.0 | 16 | 51.6 | 2 | 50.0 | 0 | 0.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 55 | 37.7 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 10 | n/a | 14 | n/a | 1 | n/a | 1 | n/a | 0 | n/a | 2 | n/a | 0 | n/a | 0 | n/a | 2 | n/a | 15 | n/a | 45 | n/a | |
Subtotal North America | 355 | 44.2 | 937 | 43.4 | 73 | 36.0 | 109 | 43.6 | 92 | 38.8 | 76 | 33.2 | 90 | 43.3 | 107 | 43.0 | 112 | 45.2 | 103 | 39.2 | 2,054 | 42.4 | |
Africa | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 11 | 22.4 | 16 | 2.4 | 0 | 0.0 | 0 | 0.0 | 2 | 1.9 | 0 | 0.0 | 0 | 0.0 | 1 | 1.0 | 0 | 0.0 | 0 | 0.0 | 30 | 2.0 | |
Confirmed not infected | 38 | 77.6 | 657 | 97.6 | 89 | 100.0 | 99 | 100.0 | 101 | 98.1 | 112 | 100.0 | 95 | 100.0 | 100 | 99.0 | 95 | 100.0 | 106 | 100.0 | 1,492 | 98.0 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 112 | 88.2 | 139 | 80.3 | 3 | 75.0 | 2 | 100.0 | 1 | 100.0 | 1 | 100.0 | 1 | 100.0 | 0 | 0.0 | 1 | 100.0 | 1 | 50.0 | 261 | 83.7 | |
Confirmed not infected | 15 | 11.8 | 34 | 19.7 | 1 | 25.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 50.0 | 51 | 16.3 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 3 | n/a | 5 | n/a | 0 | n/a | 0 | n/a | 2 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 2 | n/a | 7 | n/a | 19 | n/a | |
Subtotal Africa | 179 | 22.3 | 851 | 39.4 | 93 | 45.8 | 101 | 40.4 | 106 | 44.7 | 113 | 49.3 | 96 | 46.2 | 101 | 40.6 | 98 | 39.5 | 115 | 43.7 | 1,853 | 38.2 | |
Caribbean | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 21 | 24.1 | 5 | 3.0 | 1 | 8.3 | 0 | 0.0 | 1 | 7.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 28 | 7.7 | |
Confirmed not infected | 66 | 75.9 | 162 | 97.0 | 11 | 91.7 | 15 | 100.0 | 12 | 92.3 | 15 | 100.0 | 11 | 100.0 | 19 | 100.0 | 11 | 100.0 | 12 | 100.0 | 334 | 92.3 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 60 | 78.9 | 21 | 77.8 | 0 | 0.0 | 1 | 100.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 83 | 78.3 | |
Confirmed not infected | 16 | 21.1 | 6 | 22.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 23 | 21.7 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 4 | n/a | 1 | n/a | 1 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 6 | n/a | |
Subtotal Caribbean | 167 | 20.8 | 195 | 9.0 | 13 | 6.4 | 16 | 6.4 | 14 | 5.9 | 16 | 7.0 | 11 | 5.3 | 19 | 7.6 | 11 | 4.4 | 12 | 4.6 | 474 | 9.8 | |
Central and South America | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 4 | 44.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 4 | 6.6 | |
Confirmed not infected | 5 | 55.6 | 27 | 100.0 | 6 | 100.0 | 0 | 0.0 | 5 | 100.0 | 4 | 100.0 | 0 | 0.0 | 2 | 100.0 | 4 | 100.0 | 4 | 100.0 | 57 | 93.4 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 9 | 100.0 | 2 | 100.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 12 | 100.0 | |
Confirmed not infected | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 0 | n/a | 2 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 2 | n/a | |
Subtotal Central and South America | 18 | 2.2 | 31 | 1.4 | 6 | 3.0 | 1 | 0.4 | 5 | 2.1 | 4 | 1.7 | 0 | 0.0 | 2 | 0.8 | 4 | 1.6 | 4 | 1.5 | 75 | 1.5 | |
Asia | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 0 | 0.0 | 2 | 3.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 1.5 | |
Confirmed not infected | 6 | 100.0 | 58 | 96.7 | 6 | 100.0 | 9 | 100.0 | 9 | 100.0 | 6 | 100.0 | 4 | 100.0 | 8 | 100.0 | 9 | 100.0 | 13 | 100.0 | 128 | 98.5 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 12 | 100.0 | 13 | 86.7 | 3 | 100.0 | 4 | 100.0 | 2 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 34 | 87.2 | |
Confirmed not infected | 0 | 0.0 | 2 | 13.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 100.0 | 1 | 100.0 | 0 | 0.0 | 5 | 12.8 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | |
Subtotal Asia | 18 | 2.2 | 75 | 3.5 | 9 | 4.4 | 13 | 5.2 | 11 | 4.6 | 6 | 2.6 | 4 | 1.9 | 10 | 4.0 | 10 | 4.0 | 13 | 4.9 | 169 | 3.5 | |
Europe | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 16.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 2.2 | |
Confirmed not infected | 5 | 83.3 | 11 | 100.0 | 1 | 100.0 | 6 | 100.0 | 1 | 100.0 | 5 | 100.0 | 2 | 100.0 | 5 | 100.0 | 6 | 100.0 | 3 | 100.0 | 45 | 97.8 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 15 | 78.9 | 3 | 100.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 19 | 79.2 | |
Confirmed not infected | 4 | 21.1 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 5 | 20.8 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 1 | n/a | 1 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 2 | n/a | |
Subtotal Europe | 26 | 3.2 | 15 | 0.7 | 2 | 1.0 | 7 | 2.8 | 1 | 0.4 | 5 | 2.2 | 2 | 1.0 | 5 | 2.0 | 6 | 2.4 | 3 | 1.1 | 72 | 1.5 | |
Unknown | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 1 | 25.0 | 3 | 9.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 4 | 4.9 | |
Confirmed not infected | 3 | 75.0 | 28 | 90.3 | 6 | 100.0 | 2 | 100.0 | 7 | 100.0 | 8 | 100.0 | 3 | 100.0 | 4 | 100.0 | 7 | 100.0 | 9 | 100.0 | 77 | 95.1 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 11 | 31.4 | 18 | 85.7 | 1 | 100.0 | 1 | 100.0 | 1 | 100.0 | 0 | 0.0 | 1 | 50.0 | 1 | 100.0 | 0 | 0.0 | 0 | 0.0 | 34 | 54.0 | |
Confirmed not infected | 24 | 68.6 | 3 | 14.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 100.0 | 1 | 50.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 29 | 46.0 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 2 | n/a | 2 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 0 | n/a | 4 | n/a | 8 | n/a | |
Subtotal Unknown | 41 | 5.1 | 54 | 2.5 | 7 | 3.4 | 3 | 1.2 | 8 | 3.4 | 9 | 3.9 | 5 | 2.4 | 5 | 2.0 | 7 | 2.8 | 13 | 4.9 | 152 | 3.1 | |
Total | Prospective cohort | ||||||||||||||||||||||
Confirmed infected | 79 | 19.9 | 51 | 2.7 | 2 | 1.1 | 6 | 2.5 | 3 | 1.3 | 0 | 0.0 | 1 | 0.5 | 1 | 0.4 | 5 | 2.1 | 0 | 0.0 | 148 | 3.6 | |
Confirmed not infected | 318 | 80.1 | 1,810 | 97.3 | 186 | 98.9 | 233 | 97.5 | 225 | 98.7 | 224 | 100.0 | 204 | 99.5 | 245 | 99.6 | 237 | 97.9 | 235 | 100.0 | 3,917 | 96.4 | |
Retrospective cohort | |||||||||||||||||||||||
Confirmed infected | 292 | 75.5 | 211 | 77.6 | 10 | 76.9 | 9 | 90.0 | 6 | 85.7 | 1 | 33.3 | 2 | 66.7 | 1 | 33.3 | 1 | 50.0 | 1 | 50.0 | 534 | 76.1 | |
Confirmed not infected | 95 | 24.5 | 61 | 22.4 | 3 | 23.1 | 1 | 10.0 | 1 | 14.3 | 2 | 66.7 | 1 | 33.3 | 2 | 66.7 | 1 | 50.0 | 1 | 50.0 | 168 | 23.9 | |
Infection status not confirmed | |||||||||||||||||||||||
Infection status not confirmed | 20 | n/a | 25 | n/a | 2 | n/a | 1 | n/a | 2 | n/a | 2 | n/a | 0 | n/a | 0 | n/a | 4 | n/a | 26 | n/a | 82 | n/a | |
Grand Total | 804 | 100.0 | 2,158 | 100.0 | 203 | 100.0 | 250 | 100.0 | 237 | 100.0 | 229 | 100.0 | 208 | 100.0 | 249 | 100.0 | 248 | 100.0 | 263 | 100.0 | 4,849 | 100.0 | |
Province | Confirmed infected | Confirmed not infected | Infection status not confirmed | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asymptomatic | Symptomatic | Died of AIDS | Died of other | LFU | Adult care | Subtotal | In-determinate | LFU | Subtotal | n | % | ||
British Columbia | 17 | 4 | 4 | 2 | 4 | 39 | 70 | 553 | 3 | 6 | 9 | 632 | 13.0 |
Alberta | 20 | 1 | 5 | 1 | 20 | 22 | 69 | 590 | 11 | 12 | 23 | 682 | 14.1 |
Saskatchewan | 17 | 1 | 1 | 0 | 2 | 4 | 25 | 271 | 5 | 2 | 7 | 303 | 6.2 |
Manitoba | 0 | 0 | 1 | 0 | 5 | 2 | 8 | 246 | 2 | 2 | 4 | 258 | 5.3 |
Ontario | 31 | 16 | 40 | 6 | 118 | 61 | 272 | 1,388 | 3 | 13 | 16 | 1,676 | 34.6 |
Quebec | 34 | 10 | 44 | 1 | 41 | 94 | 224 | 1,000 | 0 | 21 | 21 | 1,245 | 25.7 |
Atlantic | 1 | 0 | 5 | 1 | 2 | 4 | 13 | 36 | 0 | 1 | 1 | 50 | 1.0 |
Yukon/Northwest Territories | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 3 | 0.1 |
Total | 120 | 32 | 101 | 11 | 192 | 226 | 682 | 4,085 | 25 | 57 | 82 | 4,849 | 100.0 |
% of subtotal | 17.6 | 4.7 | 14.8 | 1.6 | 28.2 | 33.1 | 100.0 | 100.0 | 30.5 | 69.5 | 100.0 | n/a | n/a |
% of total | 2.5 | 0.7 | 2.1 | 0.2 | 4.0 | 4.7 | 14.1 | 84.2 | 0.5 | 1.2 | 1.7 | n/a | n/a |
Continent | Country | Cumulative number to 2015Footnote * | Number reported in 2015 | All ages rate per 100,000 population for 2015 |
---|---|---|---|---|
North America and Australia | Canada | 77,806 | 2,100 | 5.8 |
United States (2014 data)Footnote † | NR | 40,234 | 12.6 | |
United StatesFootnote † | NR | 39,513 | 12.3 | |
AustraliaFootnote ‡ | 36,171 | 1,025 | 4.4 | |
Western EuropeFootnote § | Austria | 8,805 | 264 | 3.1 |
Andorra | 78 | 4 | 5.7 | |
Belgium | 28,909 | 1,001 | 8.9 | |
Denmark | 7,105 | 277 | 4.9 | |
Finland | 3,573 | 174 | 3.2 | |
France | 71,261 | 3,943 | 5.9 | |
Germany | 57,251 | 3,674 | 4.5 | |
Greece | 15,220 | 691 | 6.4 | |
Iceland | 333 | 12 | 3.6 | |
Ireland | 7,835 | 486 | 10.5 | |
Israel | 8,896 | 428 | 5.3 | |
Italy | 37,023 | 3,444 | 5.7 | |
Luxembourg | 1,443 | 57 | 10.1 | |
Malta | 324 | 61 | 14.2 | |
Netherlands | 24,085 | 802 | 4.7 | |
Norway | 5,858 | 221 | 4.3 | |
Portugal | 54,297 | 990 | 9.5 | |
San Marino | 87 | 2 | 6.3 | |
Spain | 39,352 | 3,428 | 7.4 | |
Sweden | 12,199 | 447 | 4.6 | |
Switzerland | 35,001 | 537 | 6.5 | |
United Kingdom | 145,552 | 6,078 | 9.4 | |
Page details
- Date modified: